PROAIR DIGIHALER Drug Patent Profile
✉ Email this page to a colleague
When do Proair Digihaler patents expire, and when can generic versions of Proair Digihaler launch?
Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. There are twenty-one patents protecting this drug.
This drug has three hundred and forty-three patent family members in twenty-nine countries.
The generic ingredient in PROAIR DIGIHALER is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Proair Digihaler
A generic version of PROAIR DIGIHALER was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROAIR DIGIHALER?
- What are the global sales for PROAIR DIGIHALER?
- What is Average Wholesale Price for PROAIR DIGIHALER?
Summary for PROAIR DIGIHALER
| International Patents: | 343 |
| US Patents: | 21 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 81 |
| Clinical Trials: | 1 |
| Patent Applications: | 5,404 |
| Drug Prices: | Drug price information for PROAIR DIGIHALER |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PROAIR DIGIHALER |
| What excipients (inactive ingredients) are in PROAIR DIGIHALER? | PROAIR DIGIHALER excipients list |
| DailyMed Link: | PROAIR DIGIHALER at DailyMed |
Recent Clinical Trials for PROAIR DIGIHALER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Teva Branded Pharmaceutical Products R&D, Inc. | Early Phase 1 |
| University of North Carolina, Chapel Hill | Early Phase 1 |
| Wake Forest University Health Sciences | Early Phase 1 |
Pharmacology for PROAIR DIGIHALER
| Drug Class | beta2-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta2-Agonists |
US Patents and Regulatory Information for PROAIR DIGIHALER
PROAIR DIGIHALER is protected by twenty-one US patents.
Patents protecting PROAIR DIGIHALER
Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dry powder inhalation apparatus
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Drug delivery device with electronics and power management
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Inhalation device with integrated electronics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Drug delivery device with electronics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Drug delivery device with electronics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Drug delivery device with electronics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Drug delivery device with electronics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dry powder inhalation apparatus
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dry powder inhalation apparatus
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dose counter for inhaler having a bore and shaft arrangement
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROAIR DIGIHALER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROAIR DIGIHALER
See the table below for patents covering PROAIR DIGIHALER around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| South Korea | 101628934 | ⤷ Sign Up | |
| Austria | 281861 | ⤷ Sign Up | |
| South Korea | 20130103825 | DOSE COUNTERS FOR INHALERS, INHALERS AND SHAFTS THEREOF | ⤷ Sign Up |
| Poland | 2514465 | ⤷ Sign Up | |
| South Korea | 101618932 | ⤷ Sign Up | |
| United Kingdom | 0115519 | ⤷ Sign Up | |
| San Marino | T201500025 | Contatori di dosi per inalatori e inalatori | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
